Advanced Proteome Therapeutics (TSXV:APC.H) OCF Margin %: 0.00% (As of Apr. 2023)


What is Advanced Proteome Therapeutics OCF Margin %?

Advanced Proteome Therapeutics TSXV:APC.H OCF Margin % is 0.00% as of Apr. 2023.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Advanced Proteome Therapeutics's Cash Flow from Operations for the three months ended in Apr. 2023 was C$-0.96 Mil. Advanced Proteome Therapeutics's Revenue for the three months ended in Apr. 2023 was C$0.00 Mil. Therefore, Advanced Proteome Therapeutics's OCF Margin % for the quarter that ended in Apr. 2023 was 0.00%.

As of today, Advanced Proteome Therapeutics's current OCF Yield % is -851.94%.

The historical rank and industry rank for Advanced Proteome Therapeutics's OCF Margin % or its related term are showing as below:


TSXV:APC.H's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -66.52
* Ranked among companies with meaningful OCF Margin % only.

Advanced Proteome Therapeutics OCF Margin % Related Terms

Advanced Proteome Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Advanced Proteome Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced Proteome Therapeutics OCF Margin % Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Advanced Proteome Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Advanced Proteome Therapeutics's OCF Margin for the fiscal year that ended in Jul. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Jul. 2022 )/Revenue (A: Jul. 2022 )
=-0.898/0
= %

Advanced Proteome Therapeutics's OCF Margin for the quarter that ended in Apr. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Apr. 2023 )/Revenue (Q: Apr. 2023 )
=-0.96/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Advanced Proteome Therapeutics (TSXV:APC.H) has a OCF Margin % of 0.00% as of Apr. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Advanced Proteome Therapeutics and its competitors.
Is Advanced Proteome Therapeutics' OCF Margin % too high?
Advanced Proteome Therapeutics' current OCF Margin % is 0.00%.
How does Advanced Proteome Therapeutics' OCF Margin % compare to VRTX and REGN?
Advanced Proteome Therapeutics' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Advanced Proteome Therapeutics and its competitors. Advanced Proteome Therapeutics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced Proteome Therapeutics stock overvalued right now?
Advanced Proteome Therapeutics (TSXV:APC.H) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Advanced Proteome Therapeutics (TSXV:APC.H), the current OCF Margin % is 0.00% as of Apr. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced Proteome Therapeutics Business Description

Address 104 8337 Eastlake Drive, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.